17 November 2014
Putin signed a decree on the establishment of new health centers
Ru-Facts.com
In 2015 in Moscow will have several national medical research centers. The corresponding decree was signed by Russian President Vladimir Putin said after meeting on federal funding of medical organizations. List of instructions published on the Kremlin website.
07 November 2014
India asks Russia for more market access
The Hindu and Business Line
India wants greater market access in Russia for pharmaceuticals, automotive, textile and value added agricultural products, Commerce and Industry Minister Nirmala Sitharaman has said.
06 November 2014
Russian and Slovenian scientists develop new integrated cancer therapy
MARCHMONT Innovation News
Scientists from Russia’s Tomsk in Siberia and their colleagues from Slovenia have come up with a new cancer therapy believed to be “unrivaled” globally and preventing resistance in patients, the Russian news agency RIA Novosti reported. According to Academician Sergei Psakhye, the director of Tomsk’s Institute of Strengths Physics and Materials Science (ISPMS) whose words were quoted in the news, the researchers have learned how to inhibit the growth and multiplication of cancerous cells, using a special material.
14 October 2014
New antiviral drug to go into production in Urals
MARCHMONT Innovation News
A new antiviral drug called “Triasavirin” is expected to soon be put into production in the Urals; the biotech solution is believed to be based on an innovative technology of directly impacting a virus, the Skolkovo Foundation website reported . The Ural Center for Biopharma Technologies (UCBT), the developer of the solution, is a Skolkovo resident.
15 September 2014
Ministry of Industry and explained what restrictions affect foreign PM
Market Access Solutions
Ministry of Industry and Trade has explained its position on foreign medicines, whose participation in the public procurement plan to cap. Developed a draft resolution will help the Ministry of Industry in 2018 90% of the domestic market to provide domestic medicines.
15 September 2014
Russia does not plan to ban drug imports from Western countries
ThePharmaLetter
The Russian government has no plans to impose a ban on the pharmaceutical imports from the European Union and the USA, as proposed by some local top-officials, as a response to the next package of sanctions against Russia, which was yesterday approved by the EU. According to Russian Prime Minister Dmitry Medvedev, such a measure is currently considered as destructive.
12 September 2014
Russia to expand cooperation in healthcare with BRICS countries
ITAR TASS
Deputy Foreign Minister Sergei Ryabkov says Russia had transformed from being a recipient of international assistance in healthcare into one of the largest donors
Clearside Biomedical, Inc., announces the U.S. Patent and Trademark Office (USPTO) granted U.S. Patent Application No. 13/447,246 as U.S. Patent No. 8,808,225 in a patent titled, "Methods and Devices for Drug Delivery to Ocular Tissue Using Microneedle." This is the fourth patent allowance in the U.S. related to its proprietary microneedle drug delivery methods and devices.
Clearside Biomedical, Inc. Completes $16 Million Series B Financing
Clearside Biomedical, Inc., today announced the closing of a $16 million Series B financing. The financing included new investor RusnanoMedInvest (RMI) and existing investors Hatteras Venture Partners, Santen Pharmaceuticals Co. Ltd., Mountain Group Capital and Georgia Research Alliance Venture Fund.
01 September 2014
Russian Scientists Develop Method for Earlier Detection of Cancer
RIA Novosti
Scientists from a subsidiary of the SIGMA.Novosibirsk nanotechnology center, a project run by the state-owned RUSNANO Corporation, have developed a technology that detects cancer in very early stages and can be employed at outpatient clinics, said a Friday statement on the center’s website.
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.